Literature DB >> 14532198

emm typing of M nontypeable invasive group A streptococcal isolates in Israel.

Allon E Moses1, Carlos Hidalgo-Grass, Mary Dan-Goor, Joseph Jaffe, Ilanit Shetzigovsky, Miriam Ravins, Zinaida Korenman, Ronit Cohen-Poradosu, Ran Nir-Paz.   

Abstract

We performed emm typing of M nontypeable invasive group A streptococcal (GAS) isolates collected in a prospective population-based study in Israel. One hundred twenty of 131 isolates (92%) had emm sequences compatible with GAS, consisting of 51 different emm types. Eleven isolates were found to be group G streptococcus. Of the 120 isolates, 55 (46%) belonged to 32 types for which there were no typing sera available in the Streptococcal Reference Laboratory in Israel. The other 65 (64%) isolates, consisting of 19 types, had sera available and therefore could have been serotyped. Forty-three isolates had T and emm types which were not correlated according to standard M-typing protocols and were therefore missed. The principal effect of emm typing was the addition of 32 types not previously identified in Israel and the discovery of new associations between emm and T types. emm typing did not significantly change the proportion of M types; the five most common types were 3, 28, 2, 62, and 41. Twenty different types comprised 80% of all isolates. No new emm sequences were discovered. emm typing emphasized the unusually low incidence of M1 strains causing severe disease in Israel. As serological typing of GAS becomes more problematic due to lack of sera and the appearance of new emm types, reference laboratories should replace M typing with emm sequence typing. Development of a GAS vaccine relies on the emm type distributions in different geographical locations. In our study, 7% of isolates (types 41 and 62) are not included in a 26-valent vaccine that is being studied.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14532198      PMCID: PMC254353          DOI: 10.1128/JCM.41.10.4655-4659.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Immunogenicity of a 26-valent group A streptococcal vaccine.

Authors:  Mary C Hu; Michael A Walls; Steven D Stroop; Mark A Reddish; Bernard Beall; James B Dale
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

2.  Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999.

Authors:  Katherine L O'Brien; Bernard Beall; Nancy L Barrett; Paul R Cieslak; Arthur Reingold; Monica M Farley; Richard Danila; Elizabeth R Zell; Richard Facklam; Benjamin Schwartz; Anne Schuchat
Journal:  Clin Infect Dis       Date:  2002-07-10       Impact factor: 9.079

3.  Group A streptococcal genotypes from pediatric throat isolates in Rome, Italy.

Authors:  G Dicuonzo; G Gherardi; G Lorino; S Angeletti; M De Cesaris; E Fiscarelli; D E Bessen; B Beall
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

4.  Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm124.

Authors:  Richard F Facklam; Diana R Martin; Marguerite Lovgren; Dwight R Johnson; Androulla Efstratiou; Terry A Thompson; Sonia Gowan; Paula Kriz; Gregory J Tyrrell; Edward Kaplan; Bernard Beall
Journal:  Clin Infect Dis       Date:  2001-11-26       Impact factor: 9.079

5.  Characterization of a mouse-passaged, highly encapsulated variant of group A streptococcus in in vitro and in vivo studies.

Authors:  M Ravins; J Jaffe; E Hanski; I Shetzigovski; S Natanson-Yaron; A E Moses
Journal:  J Infect Dis       Date:  2000-10-18       Impact factor: 5.226

6.  Epidemiological analysis of non-M-typeable group A Streptococcus isolates from a Thai population in northern Thailand.

Authors:  S Pruksakorn; N Sittisombut; C Phornphutkul; C Pruksachatkunakorn; M F Good; E Brandt
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

7.  [Streptococcus dysgalactiae subsp. equisimilis possessing Lancefield's group A antigen].

Authors:  Chihiro Katsukawa; Aki Tamaru; Yoshiro Morikawa
Journal:  Kansenshogaku Zasshi       Date:  2002-03

8.  Typing of Streptococcus pyogenes strains isolated from throat infections in the region of Aachen, Germany.

Authors:  C M Brandt; B Spellerberg; M Honscha; N D Truong; B Hoevener; R Lütticken
Journal:  Infection       Date:  2001 May-Jun       Impact factor: 3.553

9.  Invasive group a streptococcal infections, Israel.

Authors:  Allon E Moses; Sara Goldberg; Zinaida Korenman; Miriam Ravins; Emanuel Hanski; Mervyn Shapiro
Journal:  Emerg Infect Dis       Date:  2002-04       Impact factor: 6.883

10.  emm typing and validation of provisional M types for group A streptococci.

Authors:  R Facklam; B Beall; A Efstratiou; V Fischetti; D Johnson; E Kaplan; P Kriz; M Lovgren; D Martin; B Schwartz; A Totolian; D Bessen; S Hollingshead; F Rubin; J Scott; G Tyrrell
Journal:  Emerg Infect Dis       Date:  1999 Mar-Apr       Impact factor: 6.883

View more
  14 in total

1.  A streptococcal protease that degrades CXC chemokines and impairs bacterial clearance from infected tissues.

Authors:  Carlos Hidalgo-Grass; Inbal Mishalian; Mary Dan-Goor; Ilia Belotserkovsky; Yoni Eran; Victor Nizet; Amnon Peled; Emanuel Hanski
Journal:  EMBO J       Date:  2006-09-14       Impact factor: 11.598

2.  International quality assurance study for characterization of Streptococcus pyogenes.

Authors:  Shona Neal; Bernard Beall; Kim Ekelund; Birgitta Henriques-Normark; Aftab Jasir; Dwight Johnson; Edward Kaplan; Marguerite Lovgren; Ralf Rene Reinert; Androulla Efstratiou
Journal:  J Clin Microbiol       Date:  2007-01-31       Impact factor: 5.948

3.  Molecular epidemiology of the sil streptococcal invasive locus in group A streptococci causing invasive infections in French children.

Authors:  Philippe Bidet; Céline Courroux; Christophe Salgueiro; Agnès Carol; Patricia Mariani-Kurkdjian; Stéphane Bonacorsi; Edouard Bingen
Journal:  J Clin Microbiol       Date:  2007-03-21       Impact factor: 5.948

4.  Genetic diversity among type emm28 group A Streptococcus strains causing invasive infections and pharyngitis.

Authors:  Nicole M Green; Stephen B Beres; Edward A Graviss; James E Allison; Allison J McGeer; Jaana Vuopio-Varkila; Rance B LeFebvre; James M Musser
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

5.  M protein gene (emm type) analysis of group A beta-hemolytic streptococci from Ethiopia reveals unique patterns.

Authors:  Wezenet Tewodros; Göran Kronvall
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

6.  Molecular epidemiology of sil locus in clinical Streptococcus pyogenes strains.

Authors:  Céline Plainvert; Márcia Dinis; Miriam Ravins; Emanuel Hanski; Gérald Touak; Nicolas Dmytruk; Agnès Fouet; Claire Poyart
Journal:  J Clin Microbiol       Date:  2014-03-26       Impact factor: 5.948

7.  Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections.

Authors:  Stephen B Beres; Gail L Sylva; Daniel E Sturdevant; Chanel N Granville; Mengyao Liu; Stacy M Ricklefs; Adeline R Whitney; Larye D Parkins; Nancy P Hoe; Gerald J Adams; Donald E Low; Frank R DeLeo; Allison McGeer; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-28       Impact factor: 11.205

8.  Characterization of sil in invasive group A and G streptococci: antibodies against bacterial pheromone peptide SilCR result in severe infection.

Authors:  Ayelet Michael-Gayego; Mary Dan-Goor; Joseph Jaffe; Carlos Hidalgo-Grass; Allon E Moses
Journal:  Infect Immun       Date:  2013-08-26       Impact factor: 3.441

9.  Epidemiology and molecular characterization of Streptococcus pyogenes recovered from scarlet fever patients in central Taiwan from 1996 to 1999.

Authors:  Chien-Shun Chiou; Tsai-Ling Liao; Tzu-Hui Wang; Hsiu-Li Chang; Jui-Cheng Liao; Chun-Chin Li
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

10.  Group G streptococcal bacteremia in Jerusalem.

Authors:  Ronit Cohen-Poradosu; Joseph Jaffe; David Lavi; Sigal Grisariu-Greenzaid; Ran Nir-Paz; Lea Valinsky; Mary Dan-Goor; Colin Block; Bernard Beall; Allon E Moses
Journal:  Emerg Infect Dis       Date:  2004-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.